levofloxacin has been researched along with 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) | Trials (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) | Recent Studies (post-2010) (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 76 | 0 | 32 |
| Protein | Taxonomy | levofloxacin (IC50) | 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol (IC50) |
|---|---|---|---|
| Phospholipase D2 | Homo sapiens (human) | 0.044 | |
| Steroid hormone receptor ERR2 | Homo sapiens (human) | 0.768 | |
| Estrogen receptor | Homo sapiens (human) | 0.4554 | |
| Progesterone receptor | Homo sapiens (human) | 0.0008 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 9.3325 | |
| Estrogen receptor | Mus musculus (house mouse) | 0.0332 | |
| Estrogen-related receptor gamma | Homo sapiens (human) | 0.3485 | |
| Estrogen-related receptor gamma | Mus musculus (house mouse) | 0.6 | |
| Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 0.0005 | |
| Phospholipase D1 | Homo sapiens (human) | 4.8 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0527 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 other study(ies) available for levofloxacin and 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |